HEADER TRANSFERASE 28-OCT-02 1N3I TITLE CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PNP WITH TRANSITION TITLE 2 STATE ANALOG DADME-IMMH COMPND MOL_ID: 1; COMPND 2 MOLECULE: PURINE NUCLEOSIDE PHOSPHORYLASE; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: PNP; COMPND 5 EC: 2.4.2.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS; SOURCE 3 ORGANISM_TAXID: 1773; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 5 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET-23A(+) KEYWDS TRANSITION STATE COMPLEX, TRIMER, PNP, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR A.LEWANDOWICZ,W.SHI,G.B.EVANS,P.C.TYLER,R.H.FURNEAUX,L.A.BASSO, AUTHOR 2 D.S.SANTOS,S.C.ALMO,V.L.SCHRAMM REVDAT 5 25-OCT-23 1N3I 1 REMARK REVDAT 4 19-DEC-18 1N3I 1 COMPND HETNAM HETSYN FORMUL REVDAT 4 2 1 ATOM REVDAT 3 24-FEB-09 1N3I 1 VERSN REVDAT 2 27-JAN-04 1N3I 1 HETSYN REVDAT 1 30-SEP-03 1N3I 0 JRNL AUTH A.LEWANDOWICZ,W.SHI,G.B.EVANS,P.C.TYLER,R.H.FURNEAUX, JRNL AUTH 2 L.A.BASSO,D.S.SANTOS,S.C.ALMO,V.L.SCHRAMM JRNL TITL OVER-THE-BARRIER TRANSITION STATE ANALOGUES PROVIDE NEW JRNL TITL 2 CHEMISTRIES FOR INHIBITOR DESIGN: THE CASE OF PURINE JRNL TITL 3 NUCLEOSIDE PHOSPHORYLASE JRNL REF BIOCHEMISTRY V. 42 6057 2003 JRNL REFN ISSN 0006-2960 JRNL PMID 12755607 JRNL DOI 10.1021/BI0343830 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.8 REMARK 3 NUMBER OF REFLECTIONS : 59299 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.183 REMARK 3 FREE R VALUE : 0.213 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 6018 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.003 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.02 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 80.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 7419 REMARK 3 BIN R VALUE (WORKING SET) : 0.1810 REMARK 3 BIN FREE R VALUE : 0.2180 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 821 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.008 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5676 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 72 REMARK 3 SOLVENT ATOMS : 432 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 12.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.19000 REMARK 3 B22 (A**2) : -1.19000 REMARK 3 B33 (A**2) : 2.37000 REMARK 3 B12 (A**2) : -0.28000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.18 REMARK 3 ESD FROM SIGMAA (A) : -0.0 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.22 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.06 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.920 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1N3I COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 31-OCT-02. REMARK 100 THE DEPOSITION ID IS D_1000017472. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-JUN-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : MIRROR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 59925 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.8 REMARK 200 DATA REDUNDANCY : 5.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.03600 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 45.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 76.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.10500 REMARK 200 <I/SIGMA(I)> FOR SHELL : 10.30 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 1G2O REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.15 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.37 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG4000, MAGNESIUM CHLORIDE, TRIS, PH REMARK 280 8.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 85.84200 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 42.92100 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 42.92100 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 85.84200 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS THE TRIMER IN THE ASYMMETRIC REMARK 300 UNIT. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7970 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25280 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -66.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 ASP A 3 REMARK 465 PRO A 4 REMARK 465 ARG A 5 REMARK 465 PRO A 6 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 ASP B 3 REMARK 465 PRO B 4 REMARK 465 ARG B 5 REMARK 465 PRO B 6 REMARK 465 MET C 1 REMARK 465 ALA C 2 REMARK 465 ASP C 3 REMARK 465 PRO C 4 REMARK 465 ARG C 5 REMARK 465 PRO C 6 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 239 CG CD OE1 OE2 REMARK 470 GLU B 239 CG CD OE1 OE2 REMARK 470 GLU C 239 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 161 115.69 -34.70 REMARK 500 SER A 208 -155.36 -158.69 REMARK 500 THR A 209 -49.32 63.60 REMARK 500 SER B 161 115.11 -36.23 REMARK 500 SER B 208 -154.29 -157.39 REMARK 500 THR B 209 -48.07 63.57 REMARK 500 SER C 161 117.82 -38.75 REMARK 500 SER C 208 -152.74 -154.58 REMARK 500 THR C 209 -47.66 61.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 B 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 C 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DIH A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DIH B 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DIH C 403 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1G2O RELATED DB: PDB REMARK 900 1G2O CONTAINS MYCOBACTERIUM TUBERCULOSIS PNP WITH IMMH DBREF 1N3I A 1 268 UNP P0A538 PUNA_MYCTU 1 268 DBREF 1N3I B 1 268 UNP P0A538 PUNA_MYCTU 1 268 DBREF 1N3I C 1 268 UNP P0A538 PUNA_MYCTU 1 268 SEQRES 1 A 268 MET ALA ASP PRO ARG PRO ASP PRO ASP GLU LEU ALA ARG SEQRES 2 A 268 ARG ALA ALA GLN VAL ILE ALA ASP ARG THR GLY ILE GLY SEQRES 3 A 268 GLU HIS ASP VAL ALA VAL VAL LEU GLY SER GLY TRP LEU SEQRES 4 A 268 PRO ALA VAL ALA ALA LEU GLY SER PRO THR THR VAL LEU SEQRES 5 A 268 PRO GLN ALA GLU LEU PRO GLY PHE VAL PRO PRO THR ALA SEQRES 6 A 268 ALA GLY HIS ALA GLY GLU LEU LEU SER VAL PRO ILE GLY SEQRES 7 A 268 ALA HIS ARG VAL LEU VAL LEU ALA GLY ARG ILE HIS ALA SEQRES 8 A 268 TYR GLU GLY HIS ASP LEU ARG TYR VAL VAL HIS PRO VAL SEQRES 9 A 268 ARG ALA ALA ARG ALA ALA GLY ALA GLN ILE MET VAL LEU SEQRES 10 A 268 THR ASN ALA ALA GLY GLY LEU ARG ALA ASP LEU GLN VAL SEQRES 11 A 268 GLY GLN PRO VAL LEU ILE SER ASP HIS LEU ASN LEU THR SEQRES 12 A 268 ALA ARG SER PRO LEU VAL GLY GLY GLU PHE VAL ASP LEU SEQRES 13 A 268 THR ASP ALA TYR SER PRO ARG LEU ARG GLU LEU ALA ARG SEQRES 14 A 268 GLN SER ASP PRO GLN LEU ALA GLU GLY VAL TYR ALA GLY SEQRES 15 A 268 LEU PRO GLY PRO HIS TYR GLU THR PRO ALA GLU ILE ARG SEQRES 16 A 268 MET LEU GLN THR LEU GLY ALA ASP LEU VAL GLY MET SER SEQRES 17 A 268 THR VAL HIS GLU THR ILE ALA ALA ARG ALA ALA GLY ALA SEQRES 18 A 268 GLU VAL LEU GLY VAL SER LEU VAL THR ASN LEU ALA ALA SEQRES 19 A 268 GLY ILE THR GLY GLU PRO LEU SER HIS ALA GLU VAL LEU SEQRES 20 A 268 ALA ALA GLY ALA ALA SER ALA THR ARG MET GLY ALA LEU SEQRES 21 A 268 LEU ALA ASP VAL ILE ALA ARG PHE SEQRES 1 B 268 MET ALA ASP PRO ARG PRO ASP PRO ASP GLU LEU ALA ARG SEQRES 2 B 268 ARG ALA ALA GLN VAL ILE ALA ASP ARG THR GLY ILE GLY SEQRES 3 B 268 GLU HIS ASP VAL ALA VAL VAL LEU GLY SER GLY TRP LEU SEQRES 4 B 268 PRO ALA VAL ALA ALA LEU GLY SER PRO THR THR VAL LEU SEQRES 5 B 268 PRO GLN ALA GLU LEU PRO GLY PHE VAL PRO PRO THR ALA SEQRES 6 B 268 ALA GLY HIS ALA GLY GLU LEU LEU SER VAL PRO ILE GLY SEQRES 7 B 268 ALA HIS ARG VAL LEU VAL LEU ALA GLY ARG ILE HIS ALA SEQRES 8 B 268 TYR GLU GLY HIS ASP LEU ARG TYR VAL VAL HIS PRO VAL SEQRES 9 B 268 ARG ALA ALA ARG ALA ALA GLY ALA GLN ILE MET VAL LEU SEQRES 10 B 268 THR ASN ALA ALA GLY GLY LEU ARG ALA ASP LEU GLN VAL SEQRES 11 B 268 GLY GLN PRO VAL LEU ILE SER ASP HIS LEU ASN LEU THR SEQRES 12 B 268 ALA ARG SER PRO LEU VAL GLY GLY GLU PHE VAL ASP LEU SEQRES 13 B 268 THR ASP ALA TYR SER PRO ARG LEU ARG GLU LEU ALA ARG SEQRES 14 B 268 GLN SER ASP PRO GLN LEU ALA GLU GLY VAL TYR ALA GLY SEQRES 15 B 268 LEU PRO GLY PRO HIS TYR GLU THR PRO ALA GLU ILE ARG SEQRES 16 B 268 MET LEU GLN THR LEU GLY ALA ASP LEU VAL GLY MET SER SEQRES 17 B 268 THR VAL HIS GLU THR ILE ALA ALA ARG ALA ALA GLY ALA SEQRES 18 B 268 GLU VAL LEU GLY VAL SER LEU VAL THR ASN LEU ALA ALA SEQRES 19 B 268 GLY ILE THR GLY GLU PRO LEU SER HIS ALA GLU VAL LEU SEQRES 20 B 268 ALA ALA GLY ALA ALA SER ALA THR ARG MET GLY ALA LEU SEQRES 21 B 268 LEU ALA ASP VAL ILE ALA ARG PHE SEQRES 1 C 268 MET ALA ASP PRO ARG PRO ASP PRO ASP GLU LEU ALA ARG SEQRES 2 C 268 ARG ALA ALA GLN VAL ILE ALA ASP ARG THR GLY ILE GLY SEQRES 3 C 268 GLU HIS ASP VAL ALA VAL VAL LEU GLY SER GLY TRP LEU SEQRES 4 C 268 PRO ALA VAL ALA ALA LEU GLY SER PRO THR THR VAL LEU SEQRES 5 C 268 PRO GLN ALA GLU LEU PRO GLY PHE VAL PRO PRO THR ALA SEQRES 6 C 268 ALA GLY HIS ALA GLY GLU LEU LEU SER VAL PRO ILE GLY SEQRES 7 C 268 ALA HIS ARG VAL LEU VAL LEU ALA GLY ARG ILE HIS ALA SEQRES 8 C 268 TYR GLU GLY HIS ASP LEU ARG TYR VAL VAL HIS PRO VAL SEQRES 9 C 268 ARG ALA ALA ARG ALA ALA GLY ALA GLN ILE MET VAL LEU SEQRES 10 C 268 THR ASN ALA ALA GLY GLY LEU ARG ALA ASP LEU GLN VAL SEQRES 11 C 268 GLY GLN PRO VAL LEU ILE SER ASP HIS LEU ASN LEU THR SEQRES 12 C 268 ALA ARG SER PRO LEU VAL GLY GLY GLU PHE VAL ASP LEU SEQRES 13 C 268 THR ASP ALA TYR SER PRO ARG LEU ARG GLU LEU ALA ARG SEQRES 14 C 268 GLN SER ASP PRO GLN LEU ALA GLU GLY VAL TYR ALA GLY SEQRES 15 C 268 LEU PRO GLY PRO HIS TYR GLU THR PRO ALA GLU ILE ARG SEQRES 16 C 268 MET LEU GLN THR LEU GLY ALA ASP LEU VAL GLY MET SER SEQRES 17 C 268 THR VAL HIS GLU THR ILE ALA ALA ARG ALA ALA GLY ALA SEQRES 18 C 268 GLU VAL LEU GLY VAL SER LEU VAL THR ASN LEU ALA ALA SEQRES 19 C 268 GLY ILE THR GLY GLU PRO LEU SER HIS ALA GLU VAL LEU SEQRES 20 C 268 ALA ALA GLY ALA ALA SER ALA THR ARG MET GLY ALA LEU SEQRES 21 C 268 LEU ALA ASP VAL ILE ALA ARG PHE HET PO4 A 301 5 HET DIH A 401 19 HET PO4 B 302 5 HET DIH B 402 19 HET PO4 C 303 5 HET DIH C 403 19 HETNAM PO4 PHOSPHATE ION HETNAM DIH 7-[[(3R,4R)-3-(HYDROXYMETHYL)-4-OXIDANYL-PYRROLIDIN-1- HETNAM 2 DIH IUM-1-YL]METHYL]-3,5-DIHYDROPYRROLO[3,2-D]PYRIMIDIN-4- HETNAM 3 DIH ONE FORMUL 4 PO4 3(O4 P 3-) FORMUL 5 DIH 3(C12 H17 N4 O3 1+) FORMUL 10 HOH *432(H2 O) HELIX 1 1 ASP A 7 GLY A 24 1 18 HELIX 2 2 TRP A 38 GLY A 46 5 9 HELIX 3 3 ALA A 55 LEU A 57 5 3 HELIX 4 4 HIS A 90 GLY A 94 5 5 HELIX 5 5 ASP A 96 VAL A 101 1 6 HELIX 6 6 VAL A 101 ALA A 110 1 10 HELIX 7 7 SER A 161 ASP A 172 1 12 HELIX 8 8 THR A 190 LEU A 200 1 11 HELIX 9 9 THR A 209 ALA A 219 1 11 HELIX 10 10 SER A 242 ALA A 252 1 11 HELIX 11 11 SER A 253 PHE A 268 1 16 HELIX 12 12 ASP B 7 GLY B 24 1 18 HELIX 13 13 TRP B 38 GLY B 46 5 9 HELIX 14 14 ALA B 55 LEU B 57 5 3 HELIX 15 15 HIS B 90 GLY B 94 5 5 HELIX 16 16 ASP B 96 VAL B 101 1 6 HELIX 17 17 VAL B 101 ALA B 110 1 10 HELIX 18 18 SER B 161 ASP B 172 1 12 HELIX 19 19 THR B 190 LEU B 200 1 11 HELIX 20 20 THR B 209 ALA B 219 1 11 HELIX 21 21 SER B 242 ALA B 252 1 11 HELIX 22 22 SER B 253 PHE B 268 1 16 HELIX 23 23 ASP C 7 GLY C 24 1 18 HELIX 24 24 TRP C 38 GLY C 46 5 9 HELIX 25 25 ALA C 55 LEU C 57 5 3 HELIX 26 26 HIS C 90 GLY C 94 5 5 HELIX 27 27 ASP C 96 VAL C 101 1 6 HELIX 28 28 VAL C 101 ALA C 110 1 10 HELIX 29 29 SER C 161 ASP C 172 1 12 HELIX 30 30 THR C 190 LEU C 200 1 11 HELIX 31 31 THR C 209 ALA C 219 1 11 HELIX 32 32 SER C 242 ARG C 267 1 26 SHEET 1 A10 THR A 50 PRO A 53 0 SHEET 2 A10 GLU A 71 ILE A 77 -1 N LEU A 72 O LEU A 52 SHEET 3 A10 HIS A 80 ALA A 86 -1 N HIS A 80 O ILE A 77 SHEET 4 A10 VAL A 30 LEU A 34 1 O VAL A 30 N LEU A 83 SHEET 5 A10 ILE A 114 GLY A 123 1 O ILE A 114 N ALA A 31 SHEET 6 A10 GLU A 222 LEU A 232 1 O GLU A 222 N MET A 115 SHEET 7 A10 PRO A 133 ASN A 141 -1 N VAL A 134 O SER A 227 SHEET 8 A10 ALA A 176 GLY A 182 1 O ALA A 176 N LEU A 135 SHEET 9 A10 LEU A 204 GLY A 206 1 O LEU A 204 N ALA A 181 SHEET 10 A10 ILE A 114 GLY A 123 -1 N GLY A 122 O VAL A 205 SHEET 1 B10 THR B 50 PRO B 53 0 SHEET 2 B10 GLU B 71 ILE B 77 -1 N LEU B 72 O LEU B 52 SHEET 3 B10 HIS B 80 ALA B 86 -1 O HIS B 80 N ILE B 77 SHEET 4 B10 VAL B 30 LEU B 34 1 O VAL B 30 N LEU B 83 SHEET 5 B10 ILE B 114 GLY B 123 1 O ILE B 114 N ALA B 31 SHEET 6 B10 GLU B 222 LEU B 232 1 O GLU B 222 N MET B 115 SHEET 7 B10 PRO B 133 ASN B 141 -1 N VAL B 134 O SER B 227 SHEET 8 B10 ALA B 176 GLY B 182 1 O ALA B 176 N LEU B 135 SHEET 9 B10 LEU B 204 GLY B 206 1 O LEU B 204 N ALA B 181 SHEET 10 B10 ILE B 114 GLY B 123 -1 N GLY B 122 O VAL B 205 SHEET 1 C10 THR C 50 PRO C 53 0 SHEET 2 C10 GLU C 71 ILE C 77 -1 N LEU C 72 O LEU C 52 SHEET 3 C10 HIS C 80 ALA C 86 -1 O HIS C 80 N ILE C 77 SHEET 4 C10 VAL C 30 LEU C 34 1 O VAL C 30 N LEU C 83 SHEET 5 C10 ILE C 114 GLY C 123 1 O ILE C 114 N ALA C 31 SHEET 6 C10 GLU C 222 LEU C 232 1 O GLU C 222 N MET C 115 SHEET 7 C10 PRO C 133 ASN C 141 -1 N VAL C 134 O SER C 227 SHEET 8 C10 ALA C 176 GLY C 182 1 O ALA C 176 N LEU C 135 SHEET 9 C10 LEU C 204 GLY C 206 1 O LEU C 204 N ALA C 181 SHEET 10 C10 ILE C 114 GLY C 123 -1 N GLY C 122 O VAL C 205 CISPEP 1 GLY A 185 PRO A 186 0 0.56 CISPEP 2 GLY B 185 PRO B 186 0 0.23 CISPEP 3 GLY C 185 PRO C 186 0 0.00 SITE 1 AC1 10 GLY A 35 SER A 36 HIS A 68 ARG A 88 SITE 2 AC1 10 HIS A 90 ASN A 119 ALA A 120 SER A 208 SITE 3 AC1 10 DIH A 401 HOH A 561 SITE 1 AC2 10 GLY B 35 SER B 36 HIS B 68 ARG B 88 SITE 2 AC2 10 HIS B 90 ASN B 119 ALA B 120 SER B 208 SITE 3 AC2 10 DIH B 402 HOH B 532 SITE 1 AC3 10 GLY C 35 SER C 36 HIS C 68 ARG C 88 SITE 2 AC3 10 HIS C 90 ASN C 119 ALA C 120 SER C 208 SITE 3 AC3 10 DIH C 403 HOH C 610 SITE 1 AC4 16 HIS A 90 TYR A 92 ALA A 120 ALA A 121 SITE 2 AC4 16 GLY A 122 TYR A 188 GLU A 189 VAL A 205 SITE 3 AC4 16 GLY A 206 MET A 207 THR A 230 ASN A 231 SITE 4 AC4 16 HIS A 243 VAL A 246 PO4 A 301 HOH A 601 SITE 1 AC5 17 HIS B 90 TYR B 92 ALA B 120 ALA B 121 SITE 2 AC5 17 GLY B 122 TYR B 188 GLU B 189 VAL B 205 SITE 3 AC5 17 GLY B 206 MET B 207 THR B 230 ASN B 231 SITE 4 AC5 17 HIS B 243 VAL B 246 PO4 B 302 HOH B 621 SITE 5 AC5 17 PHE C 153 SITE 1 AC6 17 SER C 36 HIS C 90 TYR C 92 ALA C 120 SITE 2 AC6 17 ALA C 121 GLY C 122 TYR C 188 GLU C 189 SITE 3 AC6 17 VAL C 205 GLY C 206 MET C 207 THR C 230 SITE 4 AC6 17 ASN C 231 HIS C 243 VAL C 246 PO4 C 303 SITE 5 AC6 17 HOH C 520 CRYST1 102.842 102.842 128.763 90.00 90.00 120.00 P 32 2 1 18 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009724 0.005614 0.000000 0.00000 SCALE2 0.000000 0.011228 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007766 0.00000